Tuesday, November 24, 2009, 3:26am EST - Canadian Markets open in 6 hours and 4 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

ADDEX PHARMAC N (ADXN.SW)

At 03:03 EST: 37.60 CHF  Up 0.10 (0.27%)  
MORE ON ADXN.SW
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Today, Tue, Nov 24, 2009
Addex ADX48621 Positive Primate Parkinson's Data
Marketwire (Tue 1:35am)
Mon, Nov 16, 2009
Addex ADX10059 Monotherapy is Effective on GERD Symptoms in Phase IIb Clinical Trial
Marketwire (Mon, Nov 16)
Tue, Nov 3, 2009
Addex Presents ADX10059 PD-LID Data at GPCR Drug Discovery Conference
Marketwire (Tue, Nov 3)
Mon, Sep 28, 2009
Addex Completes Enrollment of First Mid-Stage Clinical GERD Trial
Marketwire (Mon, Sep 28)
Thu, Sep 17, 2009
Laurent Massuyeau, Head of Business Development, Resigns
Marketwire (Thu, Sep 17)
Mon, Sep 14, 2009
Addex' ADX10059 has potential for Parkinson's disease levodopa induced dyskinesia (PD-LID)
Marketwire (Mon, Sep 14)
Tue, Jul 28, 2009
Addex Pharmaceuticals Reports First Half 2009 Financial Results
Marketwire (Tue, Jul 28)
Thu, Jul 23, 2009
Addex First Half 2009 Financial Results Tuesday, July 28
Marketwire (Thu, Jul 23)
Thu, Jul 16, 2009
Addex R&D Day Highlights Broadened Therapeutic Potential of Allosteric Modulation Platform to Include Cytokine Receptors as Well as GPCRs
Marketwire (Thu, Jul 16)
Addex R&D Day Highlights Broadened Therapeutic Potential of Allosteric Modulation Platform to Include Cytokine Receptors as Well as GPCRs
Marketwire (Thu, Jul 16)
Fri, Jul 10, 2009
Addex Achieves Second Milestone in Parkinson's Disease Collaboration With Merck & Co., Inc.
Marketwire (Fri, Jul 10)
Addex Achieves Second Milestone in Parkinson's Disease Collaboration with Merck & Co., Inc.
Marketwire (Fri, Jul 10)
Fri, Jul 3, 2009
Addex to Host R&D Day on July 16
Marketwire (Fri, Jul 3)
Addex to Host R&D Day on July 16
Marketwire (Fri, Jul 3)
Wed, Jun 24, 2009
Addex Partner Starts First-Ever Clinical Trial of an mGluR Positive Allosteric Modulator
Marketwire (Wed, Jun 24)
Addex Partner Starts First-Ever Clinical Trial of an mGluR Positive Allosteric Modulator
Marketwire (Wed, Jun 24)
Wed, May 27, 2009
Glutamate Receptor "mGluR5" Implicated in GERD
Marketwire (Wed, May 27)
Glutamate Receptor "mGluR5" Implicated in GERD
Marketwire (Wed, May 27)
Wed, Apr 29, 2009
Addex Presents Data on ADX10059 at the Annual Meeting of the American Academy of Neurology
Marketwire (Wed, Apr 29)
Fri, Apr 17, 2009
Addex Shareholders Approve All Board Proposals at 2009 AGM
Marketwire (Fri, Apr 17)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices